openPR Logo
Press release

Peptide Therapeutics Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities and Forecast to 2026| Sanofi, Eli Lilly, Novo Nordisk

02-10-2020 10:22 AM CET | Health & Medicine

Press release from: QY Research, INC.

Peptide Therapeutics Market Trends Analysis, Top

QY Research offers its latest report on the Global Peptide Therapeutics Market Size, Status and Forecast 2020-2026 that includes comprehensive analysis on a range of subjects such as competition, segmentation, regional expansion, and market dynamics.

Some of the Major key players operating in this Report are: Sanofi, Eli Lilly, Novo Nordisk, Takeda, Teva, Novartis, AstraZeneca, Ipsen, AbbVie, Allergan, Ferring, Merck, J & J, The Medicines

The report has covered exhaustive assessment of the current scenario and future progress of the Global Peptide Therapeutics industry. Additionally, it has touched upon aspects such as drivers, challenges, opportunities, trends, and developments pertaining to the global Peptide Therapeutics production. These projections have been obtained from research methodologies such as PESTLE analysis, SWOT analysis, and PORTER's Five Forces.

The report focuses on the micro- and macro-economic factors that are anticipated to impact the growth of the industry positively. The report has also shed light on Peptide Therapeutics sales, production, demand, consumption, and gross margin. Moreover, challenges and limitations that the business is likely to face in the forthcoming years are mapped in the report.

Latest Sample Copy of this Peptide Therapeutics Market Report(Including Full Table of Content, List of Tables & Figures, Chart)@https://www.qyresearch.com/sample-form/form/1504199/global-peptide-therapeutics-industry-research-report-growth-trends-and-competitive-analysis-2020-2026

To understand the structure, the report has segregated the global Peptide Therapeutics Market into segments comprising product type, vertical, and application. The study is done based on CAGR, share, size, production, and consumption. Besides, the report has offered region-wise analysis, wherein prospective regions and respective countries are studied. This information will act as an effective tool for the global Peptide Therapeutics players to recognize the promising areas and make effective investments in the coming future.

This report includes the following Leading Players &we can also add the other companies as you want:

Sanofi, Eli Lilly, Novo Nordisk, Takeda, Teva, Novartis, AstraZeneca, Ipsen, AbbVie, Allergan, Ferring, Merck, J & J, The Medicines

Market Segment by Type

Injection, Oral, Other, The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.Market

Market Segment by Application

Cancer, Metabolic Disorders, Central Nervous System, Other, The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.

Get Customized Report in your Inbox within 24 hours: https://www.qyresearch.com/customize-request/form/1504199/global-peptide-therapeutics-industry-research-report-growth-trends-and-competitive-analysis-2020-2026

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Peptide Therapeutics Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Peptide Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Injection
1.3.3 Oral
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Peptide Therapeutics Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Cancer
1.4.3 Metabolic Disorders
1.4.4 Central Nervous System
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Peptide Therapeutics Revenue (2015-2026)
2.1.1 Global Peptide Therapeutics Revenue (2015-2026)
2.1.2 Global Peptide Therapeutics Sales (2015-2026)
2.2 Peptide Therapeutics Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Peptide Therapeutics Sales by Regions (2015-2020)
2.2.2 Global Peptide Therapeutics Revenue by Regions (2015-2020)
2.3 Global Top Peptide Therapeutics Regions (Countries) Ranking by Market Size
2.4 Peptide Therapeutics Industry Trends
2.4.1 Peptide Therapeutics Market Top Trends
2.4.2 Market Drivers
2.4.3 Peptide Therapeutics Market Challenges
2.4.4 Porter's Five Forces Analysis
2.4.5 Primary Interviews with Key Peptide Therapeutics Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Peptide Therapeutics Manufacturers by Sales (2015-2020)
3.1.1 Global Peptide Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Global Peptide Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Peptide Therapeutics Sales in 2019
3.2 Global Top Manufacturers Peptide Therapeutics by Revenue
3.2.1 Global Peptide Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Global Peptide Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics as of 2019)
3.4 Global Peptide Therapeutics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Peptide Therapeutics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Peptide Therapeutics Market
3.7 Key Manufacturers Peptide Therapeutics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Peptide Therapeutics Historic Market Review by Type (2015-2020)
4.1.2 Global Peptide Therapeutics Sales Market Share by Type (2015-2020)
4.1.3 Global Peptide Therapeutics Revenue Market Share by Type (2015-2020)
4.1.4 Peptide Therapeutics Price by Type (2015-2020)
4.1 Global Peptide Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Peptide Therapeutics Sales Forecast by Type (2021-2026)
4.2.3 Global Peptide Therapeutics Revenue Forecast by Type (2021-2026)
4.2.4 Peptide Therapeutics Price Forecast by Type (2021-2026)

5 Global Peptide Therapeutics Market Size by Application
5.1 Global Peptide Therapeutics Historic Market Review by Application (2015-2020)
5.1.2 Global Peptide Therapeutics Sales Market Share by Application (2015-2020)
5.1.3 Global Peptide Therapeutics Revenue Market Share by Application (2015-2020)
5.1.4 Peptide Therapeutics Price by Application (2015-2020)
5.2 Global Peptide Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Peptide Therapeutics Sales Forecast by Application (2021-2026)
5.2.3 Global Peptide Therapeutics Revenue Forecast by Application (2021-2026)
5.2.4 Peptide Therapeutics Price Forecast by Application (2021-2026)

6 North America
6.1 North America Peptide Therapeutics Breakdown Data by Company
6.2 North America Peptide Therapeutics Breakdown Data by Type
6.3 North America Peptide Therapeutics Breakdown Data by Application
6.4 North America Peptide Therapeutics Breakdown Data by Countries
6.4.1 North America Peptide Therapeutics Sales by Countries
6.4.2 North America Peptide Therapeutics Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Peptide Therapeutics Breakdown Data by Company
7.2 Europe Peptide Therapeutics Breakdown Data by Type
7.3 Europe Peptide Therapeutics Breakdown Data by Application
7.4 Europe Peptide Therapeutics Breakdown Data by Countries
7.4.1 Europe Peptide Therapeutics Sales by Countries
7.4.2 Europe Peptide Therapeutics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Peptide Therapeutics Breakdown Data by Company
8.2 Asia Pacific Peptide Therapeutics Breakdown Data by Type
8.3 Asia Pacific Peptide Therapeutics Breakdown Data by Application
8.4 Asia Pacific Peptide Therapeutics Breakdown Data by Regions
8.4.1 Asia Pacific Peptide Therapeutics Sales by Regions
8.4.2 Asia Pacific Peptide Therapeutics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Peptide Therapeutics Breakdown Data by Company
9.2 Latin America Peptide Therapeutics Breakdown Data by Type
9.3 Latin America Peptide Therapeutics Breakdown Data by Application
9.4 Latin America Peptide Therapeutics Breakdown Data by Countries
9.4.1 Latin America Peptide Therapeutics Sales by Countries
9.4.2 Latin America Peptide Therapeutics Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Peptide Therapeutics Breakdown Data by Type
10.2 Middle East and Africa Peptide Therapeutics Breakdown Data by Application
10.3 Middle East and Africa Peptide Therapeutics Breakdown Data by Countries
10.3.1 Middle East and Africa Peptide Therapeutics Sales by Countries
10.3.2 Middle East and Africa Peptide Therapeutics Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi Peptide Therapeutics Products and Services
11.1.5 Sanofi SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Eli Lilly Peptide Therapeutics Products and Services
11.2.5 Eli Lilly SWOT Analysis
11.2.6 Eli Lilly Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Corporation Information
11.3.2 Novo Nordisk Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Novo Nordisk Peptide Therapeutics Products and Services
11.3.5 Novo Nordisk SWOT Analysis
11.3.6 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Takeda Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Takeda Peptide Therapeutics Products and Services
11.4.5 Takeda SWOT Analysis
11.4.6 Takeda Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Teva Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Teva Peptide Therapeutics Products and Services
11.5.5 Teva SWOT Analysis
11.5.6 Teva Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Novartis Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Novartis Peptide Therapeutics Products and Services
11.6.5 Novartis SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.7.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 AstraZeneca Peptide Therapeutics Products and Services
11.7.5 AstraZeneca SWOT Analysis
11.7.6 AstraZeneca Recent Developments
11.8 Ipsen
11.8.1 Ipsen Corporation Information
11.8.2 Ipsen Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Ipsen Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Ipsen Peptide Therapeutics Products and Services
11.8.5 Ipsen SWOT Analysis
11.8.6 Ipsen Recent Developments
11.9 AbbVie
11.9.1 AbbVie Corporation Information
11.9.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)
11.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 AbbVie Peptide Therapeutics Products and Services
11.9.5 AbbVie SWOT Analysis
11.9.6 AbbVie Recent Developments
11.10 Allergan
11.10.1 Allergan Corporation Information
11.10.2 Allergan Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Allergan Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Allergan Peptide Therapeutics Products and Services
11.10.5 Allergan SWOT Analysis
11.10.6 Allergan Recent Developments
11.11 Ferring
11.11.1 Ferring Corporation Information
11.11.2 Ferring Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Ferring Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Ferring Peptide Therapeutics Products and Services
11.11.5 Ferring SWOT Analysis
11.11.6 Ferring Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Merck Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Merck Peptide Therapeutics Products and Services
11.12.5 Merck SWOT Analysis
11.12.6 Merck Recent Developments
11.13 J & J
11.13.1 J & J Corporation Information
11.13.2 J & J Business Overview and Total Revenue (2019 VS 2018)
11.13.3 J & J Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 J & J Peptide Therapeutics Products and Services
11.13.5 J & J SWOT Analysis
11.13.6 J & J Recent Developments
11.14 The Medicines
11.14.1 The Medicines Corporation Information
11.14.2 The Medicines Business Overview and Total Revenue (2019 VS 2018)
11.14.3 The Medicines Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 The Medicines Peptide Therapeutics Products and Services
11.14.5 The Medicines SWOT Analysis
11.14.6 The Medicines Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Peptide Therapeutics Sales Channels
12.2.2 Peptide Therapeutics Distributors
12.3 Peptide Therapeutics Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Peptide Therapeutics Sales Forecast (2021-2026)
13.1.1 Global Peptide Therapeutics Sales Forecast by Regions (2021-2026)
13.1.2 Global Peptide Therapeutics Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Peptide Therapeutics Sales Forecast (2021-2026)
13.2.2 North America Peptide Therapeutics Revenue Forecast (2021-2026)
13.2.3 North America Peptide Therapeutics Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Peptide Therapeutics Sales Forecast (2021-2026)
13.3.2 Europe Peptide Therapeutics Revenue Forecast (2021-2026)
13.3.3 Europe Peptide Therapeutics Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Peptide Therapeutics Sales Forecast (2021-2026)
13.4.2 Asia Pacific Peptide Therapeutics Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Peptide Therapeutics Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Peptide Therapeutics Sales Forecast (2021-2026)
13.5.2 Latin America Peptide Therapeutics Revenue Forecast (2021-2026)
13.5.3 Latin America Peptide Therapeutics Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Peptide Therapeutics Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Peptide Therapeutics Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Peptide Therapeutics Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Contact US:
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA - 91748
USA: +1 626 428 8800
India: +91 9766 478 224
Emails - enquiry@qyresearch.com
Web - www.qyresearch.com

ABOUT US:
QY Research is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Therapeutics Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities and Forecast to 2026| Sanofi, Eli Lilly, Novo Nordisk here

News-ID: 1924958 • Views: 339

More Releases from QY Research, INC.

Relay Current Transformer Market 2022| Worldwide Industry Share, Size, Gross Mar …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Relay Current Transformer market with holistic insights into vital factors and aspects that impact future market growth. The global Relay Current Transformer market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Relay Current Transformer market and its critical dynamics, the research
LED Protector Market 2022: Global Size, Supply-Demand, Product Type and End User …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global LED Protector market with holistic insights into vital factors and aspects that impact future market growth. The global LED Protector market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global LED Protector market and its critical dynamics, the research study provides detailed
Fuse Puller Market Overview, Trend Analysis, Competitive Landscape, Forecast to …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Fuse Puller market with holistic insights into vital factors and aspects that impact future market growth. The global Fuse Puller market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Fuse Puller market and its critical dynamics, the research study provides detailed
Fuse Reducers Market Size by Top Companies, Trends by Types and Application, For …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Fuse Reducers market with holistic insights into vital factors and aspects that impact future market growth. The global Fuse Reducers market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Fuse Reducers market and its critical dynamics, the research study provides detailed

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
Peptide Therapeutics Market | Forecast up to 2024
Global Peptide Therapeutics Market: Overview This report provides in-depth region wise and country wise analysis of the peptide therapeutics market. Stakeholders of this report include manufacturers of peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market. It further provides qualitative and quantitative analysis of the global peptide therapeutics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market
Peptide Vaccine Market Peptide Vaccine Clinical Pipeline Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Peptide Vaccine: A Prologue to Sub-Unit Vaccines 1.1 Introduction 1.2 Glimpse of Antiquity 2. Need of Peptide Vaccines 2.1 Why Peptides – More Desirable 2.2 Peptide Vaccines V/S Traditional Vaccines 3. Classification of Peptide Vaccines 3.1 On the Basis of Sources Obtained 3.2 On the Basis of Length 3.3 On the Basis of
Global Natriuretic Peptide Market Research Report 2017
Report Hive Market Research Released a New Research Report of 107 pages on Title " Global Natriuretic Peptide Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Peptide Therapeutics Pipeline Insight 2015
Peptides are small molecules of varying molecular masses that consist of amino acids joined with the help of peptide bonds (CONH2). One end of the molecule consists of carboxyl (COOH2) group while the other end has amino (NH2) group giving rise to polarity. Biologically, they are very important and found to play an important role in various anabolic and catabolic processes. They are essential component of cell signaling pathways, immune
Global Peptide Vaccine Market & Pipeline Insight
Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack. Every living cell in human body has surface markers as an instrument to